PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 42 filers reported holding PROTARA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,290,215 | -30.1% | 772,584 | 0.0% | 0.03% | -18.2% |
Q2 2023 | $1,846,476 | -25.7% | 772,584 | -2.6% | 0.03% | -32.7% |
Q1 2023 | $2,483,837 | +11.6% | 793,558 | -4.5% | 0.05% | +14.0% |
Q4 2022 | $2,226,118 | -9.5% | 830,641 | 0.0% | 0.04% | -6.5% |
Q3 2022 | $2,459,000 | +1.0% | 830,641 | 0.0% | 0.05% | +4.5% |
Q2 2022 | $2,434,000 | -42.7% | 830,641 | 0.0% | 0.04% | -36.2% |
Q1 2022 | $4,245,000 | -24.3% | 830,641 | 0.0% | 0.07% | -4.2% |
Q4 2021 | $5,607,000 | +80.1% | 830,641 | +84.6% | 0.07% | +111.8% |
Q3 2021 | $3,114,000 | -29.0% | 450,000 | 0.0% | 0.03% | -22.7% |
Q2 2021 | $4,383,000 | -38.1% | 450,000 | 0.0% | 0.04% | -33.3% |
Q1 2021 | $7,083,000 | -35.0% | 450,000 | 0.0% | 0.07% | -30.5% |
Q4 2020 | $10,895,000 | +43.8% | 450,000 | 0.0% | 0.10% | 0.0% |
Q3 2020 | $7,574,000 | – | 450,000 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 2,692,594 | $8,077,883 | 2.42% |
Privium Fund Management (UK) Ltd | 119,730 | $401,096 | 0.32% |
Ikarian Capital, LLC | 188,664 | $584,859 | 0.13% |
Orbimed Advisors | 793,558 | $2,483,837 | 0.05% |
Boxer Capital, LLC | 209,227 | $655 | 0.03% |
Perceptive Advisors | 290,051 | $907,860 | 0.03% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 64,000 | $198,400 | 0.01% |
Baker Brothers Advisors | 199,671 | $624,970 | 0.00% |
BOOTHBAY FUND MANAGEMENT, LLC | 18,864 | $59,044 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 35,745 | $111,882 | 0.00% |